| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/02/2009 | WO2009064444A9 Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 07/02/2009 | WO2009063484A3 Stable pharmaceutical composition of lamotrigine |
| 07/02/2009 | WO2009063364A3 Modulators of urotensin receptor and methods of use thereof |
| 07/02/2009 | WO2009063221A3 Methods of treating or preventing inflammatory diseases of the intestinal tract |
| 07/02/2009 | WO2009061811A8 Substituted cyclopentanes having prostaglanding activity |
| 07/02/2009 | WO2009061676A3 Antagonists of pgd2 receptors |
| 07/02/2009 | WO2009061607A3 Water-immiscible materials as vehicles for drug delivery |
| 07/02/2009 | WO2009061445A3 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 07/02/2009 | WO2009061105A3 Stabilized preparation containing coenzyme q10 and process for preparation thereof |
| 07/02/2009 | WO2009058944A3 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and /or nf- kappa b activity and use thereof |
| 07/02/2009 | WO2009058898A3 Method and apparatus for diagnoses of hemangiosarcoma in mammals |
| 07/02/2009 | WO2009054004A3 Process for the preparation of sorafenib |
| 07/02/2009 | WO2009052970A3 Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors |
| 07/02/2009 | WO2009050136A3 Glucocorticoid receptor antagonists such as mifepristone for treating cushing' s syndrome |
| 07/02/2009 | WO2009049305A3 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer |
| 07/02/2009 | WO2009047792A3 Carbohydrate based toll-like receptor (tlr) antagonists |
| 07/02/2009 | WO2009047788A3 Topical composition containing the combination of mupirocin and beclomethasone |
| 07/02/2009 | WO2009047785A3 A non-aqueous topical solution of diclofenac and process for preparing the same |
| 07/02/2009 | WO2009043797A3 Salts of a cgrp antagonist, method for producing the same and use thereof as drugs |
| 07/02/2009 | WO2009042809A8 Stable imatinib compositions |
| 07/02/2009 | WO2009040092A3 Pna conjugates targeted to the emu enhancer of the igh locus as therapeutic agent for bcl-2 translocation driven follicular cell lymphoma clonal expansion |
| 07/02/2009 | WO2009037001A4 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 07/02/2009 | WO2009036059A3 Novel stat3 pathway inhibitors and cancer stem cell inhibitors |
| 07/02/2009 | WO2009035673A8 Compositions and methods for treating macular degeneration |
| 07/02/2009 | WO2009027844A3 Crf conjugates with extended half-lives |
| 07/02/2009 | WO2009027641A3 Materials and methods for exploiting synthetic lethality in mismatch repair-deficient cancers |
| 07/02/2009 | WO2009016410A3 Chemical compounds 831 |
| 07/02/2009 | WO2009013545A3 Chemical compounds |
| 07/02/2009 | WO2009012375A3 Squarate kinase inhibitors |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2009009417A3 Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion |
| 07/02/2009 | WO2009001224A3 Antivirals |
| 07/02/2009 | WO2009001097A3 Substrate reduction therapy |
| 07/02/2009 | WO2008153632A3 Compositions and methods for treating obesity and related disorders |
| 07/02/2009 | WO2008138968A4 Dosage form comprising 10-[(3s)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine, provided in a form suitable for oral administration of a daily dose of 1 mg to 3 mg |
| 07/02/2009 | WO2008137128A3 Methods of treating fungal infections |
| 07/02/2009 | WO2008106606A3 Carotenoid analogs and derivatives in the treatment of prostate cancer |
| 07/02/2009 | WO2008104590A3 Novel dosage form |
| 07/02/2009 | WO2008074001A8 Renin inhibitors for the prevention and treatment of hypertension in obese patients |
| 07/02/2009 | WO2008068427A8 Anti-microorganism terpenic composition |
| 07/02/2009 | WO2008068424A8 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 07/02/2009 | WO2008063943A4 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain |
| 07/02/2009 | WO2008004013A8 Medicament for the enhancement of cognitive function and neuroprotection |
| 07/02/2009 | WO2007122581A3 Compositions and kits of phenylephrine |
| 07/02/2009 | WO2007109045A8 Heterocyclic organic compounds for the treatment of in particular melanoma |
| 07/02/2009 | WO2007103286A3 Rate-controlled bioadhesive oral dosage formulations |
| 07/02/2009 | US20090171103 Triptolide Derivatives for Modulation of Apoptosis and Immunosuppression |
| 07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 07/02/2009 | US20090171082 Mitotic kinesin inhibitors |
| 07/02/2009 | US20090171077 Delivery of nucleic acid-like compounds |
| 07/02/2009 | US20090170957 Scyllo-inositol derivatives and their use in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence |
| 07/02/2009 | US20090170956 antimitotic; antitumor; ethylate 4-hydroxy-3-methoxybenzaldehyde with ethyl bromide to form the 4-ethoxy-; Wittig reaction with 3,4,5-trimethoxybenzyltriphenylphosphonium ylid; phosphorylation |
| 07/02/2009 | US20090170955 Fast Release Paracetamol Tablets |
| 07/02/2009 | US20090170954 Process for Recovering Florfenicol and Florfenicol Analogs |
| 07/02/2009 | US20090170953 Indentification of compounds that inhibit replication of human immunodeficiency virus |
| 07/02/2009 | US20090170952 Colchicine compositions and methods |
| 07/02/2009 | US20090170951 Phenolic Hydrazone Macrophage Migration Inhibitory Factor Inhibitors |
| 07/02/2009 | US20090170950 Inhibitors Of Neurotrypsin |
| 07/02/2009 | US20090170949 Method To Control Body Weight |
| 07/02/2009 | US20090170948 Crystal forms of O-desmethylvenlafaxine fumarate |
| 07/02/2009 | US20090170947 Disinfectant compositions, methods and systems |
| 07/02/2009 | US20090170945 Pregabalin salts |
| 07/02/2009 | US20090170944 Ophthalmic micellar compositions with enhanced stability |
| 07/02/2009 | US20090170943 moisturizing skin by contact with the product of reacting poly-hydroxy functional compound such as 1,2,3,4,5,6-hexanehexol with ethylene oxide and/or 1,2-propylene oxide and reacting the product with a C8-22 fatty acid; each oxyalkylene chain contains no more than 5 units |
| 07/02/2009 | US20090170942 Ester derivative and use thereof |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170939 Use of Fenofibrate or a Derivative Thereof for Preventing Diabetic Retinopathy |
| 07/02/2009 | US20090170937 Amino Acid Derivatives |
| 07/02/2009 | US20090170934 Manufacturing process for no-donating compounds such as no-donating diclofenac |
| 07/02/2009 | US20090170933 Method for removing a medical device from a spasmodic constriction in a bodily passageway |
| 07/02/2009 | US20090170932 Disinfectant compositions, methods and systems |
| 07/02/2009 | US20090170931 EP2 and EP4 agonists as agents for the treatment of influenza a viral infection |
| 07/02/2009 | US20090170930 Methods for directing differentiation of clonogenic neural stem cells with coumarins |
| 07/02/2009 | US20090170929 Composition for the Protection and Preservation of Organs, Tissues or Cells and the Use Thereof |
| 07/02/2009 | US20090170928 Synthesis of oligo/poly(catechins) and methods of use |
| 07/02/2009 | US20090170927 Functionalized phenolic compounds and polymers therefrom |
| 07/02/2009 | US20090170926 Antiviral agents |
| 07/02/2009 | US20090170925 Methods for prognosing the ability of a zearalenone analog compound to treat cancer |
| 07/02/2009 | US20090170923 Hcv inhibitors |
| 07/02/2009 | US20090170922 Benzimidazole derivatives and their use as a medicament |
| 07/02/2009 | US20090170921 Benzimidazole derivatives |
| 07/02/2009 | US20090170920 Substituted hydantoins |
| 07/02/2009 | US20090170919 Methods for treatment of inflammatory diseases |
| 07/02/2009 | US20090170917 Acid Mimic Compounds for the Inhibition of Isoprenyl-S-Cysteinyl Methyltransferase |
| 07/02/2009 | US20090170916 4,5-substituted pyrazole-3-carboxylic acids/esters/salts; D-amino acid oxidase (DAAO) inhibitors; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 07/02/2009 | US20090170915 POLYMORPHIC FORMS OF (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate |
| 07/02/2009 | US20090170914 Cermide Kinase Modulation |
| 07/02/2009 | US20090170913 Novel mch receptor antagonists |
| 07/02/2009 | US20090170912 Agents for combating plant pests |
| 07/02/2009 | US20090170911 Novel azole compound |
| 07/02/2009 | US20090170910 Wound healing |
| 07/02/2009 | US20090170909 N-cyclopropyl-3S-{4-methanesulfonyl-2S-[2,2,2-trifluoro-1S-(4-fluoro-phenyl)-ethylamino]-butyrylamino}-2-oxo-pentanamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, systemic lupus erythemotasus, asthma, pain, and atheros |
| 07/02/2009 | US20090170908 Spiro compounds and pharmaceutical use thereof |
| 07/02/2009 | US20090170907 Chemical Compounds |
| 07/02/2009 | US20090170906 Hcv inhibitors |
| 07/02/2009 | US20090170905 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 07/02/2009 | US20090170904 Substituted benzimidazoles and methods of their use |
| 07/02/2009 | US20090170903 Ester derivatives as phosphodiesterase inhibitors |
| 07/02/2009 | US20090170902 Compounds which potentiate glutamate receptor and uses thereof in medicine |